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Increased protein loss during peritonitis associated with
peritoneal dialysis is neutrophil dependent
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negative bacterial peritonitis in a rabbit model of peritonealIncreased protein loss during peritonitis associated with perito-
dialysis is PMN dependent.neal dialysis is neutrophil dependent.
Background. Peritonitis in peritoneal dialysis patients is ac-
companied by an enhanced migration of neutrophils (PMNs)
and increased protein loss into the peritoneal cavity; however, Peritonitis is a major complication of peritoneal dial-the role of PMNs in governing increased protein loss during
ysis (PD) therapy, and its frequent occurrence is an ob-peritonitis associated with peritoneal dialysis is unknown.
stacle to the more widespread application of PD. Perito-Methods. We determined the importance of PMNs in gov-
erning changes in peritoneal permeability to protein in New nitis in chronic PD patients results in rapid leukocyte
Zealand White rabbits in which acute peritonitis was induced migration into the peritoneal cavity and increased per-
by adding 4 3 106 colony-forming units of Escherichia coli to meability of the peritoneal membrane to both small sol-35 mL/kg of 0.9% saline dialysate. The total leukocyte and
utes and protein. Although peritoneal permeability usu-PMN migration into the peritoneal cavity was assessed by dif-
ally returns to normal after resolution of the infection,ferential cell counts in the dialysate, and peritoneal permeabil-
ity to protein was evaluated by calculating the dialysate to plasma increases in peritoneal permeability during peritonitis
concentration ratio for total protein as a function of time during may contribute to poor fluid balance [1, 2], high rates of
a six- or eight-hour dwell. In series 1 experiments, leukocytes protein loss [3], and low serum albumin concentrations
were depleted from the rabbit circulation by an intravenous
[4, 5]. Increased peritoneal permeability to small solutesinjection of mustine (1.2 mg/kg) three days before the experi-
and protein during chronic PD therapy has also beenment; in series 2 experiments, integrin-dependent PMN migra-
tion into the peritoneal cavity was inhibited by an intravenous associated with a poor clinical outcome [6–8].
injection of monoclonal antibody (mAb) 60.3 (2 mg/kg) di- Although enhanced migration of neutrophils (PMNs)
rected against the integrin CD18 on leukocytes five minutes into the peritoneal cavity is important for resolution of
before the experiment. the infection during peritonitis, the role of PMN acti-Results. In series 1 experiments, mustine decreased circulat-
vation and migration in governing increased peritonealing leukocytes by 82 6 5% (mean 6 SEM) and circulating
permeability to small solutes and protein has not beenPMNs by 93 6 3%. Total leukocyte and PMN migration into
the peritoneal cavity and peritoneal permeability to protein extensively studied. Previous work has shown that ex-
were decreased in mustine-treated rabbits after exposure to travasation of PMNs is essential for edema formation
E. coli in the dialysate to levels similar to those found in rabbits and enhanced vascular permeability to proteins, espe-
without bacterial peritonitis. In series 2 experiments, an intra-
cially albumin, during inflammation in various tissues,venous injection of anti-CD18 antibody also abrogated both
including the skin [9, 10], lung [11–13], intestines [14, 15],the enhanced PMN migration into the peritoneal cavity and
the increased peritoneal permeability to protein after exposure and brain [16]; however, recent studies in the mouse have
to E. coli in the dialysate. not supported an important role for PMNs in governing
Conclusions. PMN migration into the peritoneal cavity is peritoneal permeability to protein [17, 18]. For example,
integrin dependent. Increased protein loss during acute, gram-
an intravenous injection of a monoclonal antibody (mAb)
directed against the CD11b subunit of the CD11b/CD18
adhesion molecule on leukocytes partially inhibited theKey words: adhesion molecule, creatinine, integrin, leukocyte, mustine,
rabbit. increase in PMN migration into the peritoneal cavity
that was induced by intraperitoneal injection of zymosan.
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Table 1. Number of replicate experiments performed (N) and75%. Other work using mutant mice deficient in adhe-
measured drain volumes (mean 6 SEM) for the
sion molecules located on vascular endothelial cells different interventions
showed that complete inhibition of PMN migration into
Drainedthe peritoneal cavity during Streptococcus pneumoniae- Experimental Intravenous Dialysate volume
induced peritonitis required mice deficient in both P-selec- series injection composition N mL
tin and intercellular adhesion molecule-1 (ICAM-1) [18]. 1 Saline Saline 1 E. coli 6 6065
Mustine Saline 1 E. coli 6 4966In those experiments, the absence of both P-selectin and
Saline Saline 6 47615ICAM-1 reduced peritonitis-induced edema formation
Mustine Saline 6 50610
and enhancement of vascular permeability to albumin,
2 Saline Saline 1 E. coli 5 5467
but not down to peritonitis-free levels. mAb 60.3 Saline 1 E. coli 5 36611
mAb 60.3 Saline 2 10610We have previously described a rabbit model of acute
peritonitis that demonstrates two cardinal features of
peritonitis associated with clinical PD, namely, enhanced
PMN migration and increased protein loss into the peri-
toneal cavity (abstract; Liu et al, J Am Soc Nephrol 5:462, 60.3. Table 1 summarizes the type and the number of
replicates for each intervention performed in both series1994). In the present study, we exploited this model
to evaluate the role of PMNs in governing increased 1 and 2 experiments, identifying the type of intravenous
injection and the contents of the dialysate.peritoneal permeability to protein during bacterial peri-
tonitis.
Surgical procedure and experimental protocol
The rabbit model of PD used in these experiments
METHODS
has been previously described [21, 22]. In brief, male
Materials NZW rabbits (2.6 to 3.7 kg body wt) fasted overnight
and were anesthetized by an intramuscular injection ofMustine hydrochloride and creatinine were purchased
from Sigma Chemical (St. Louis, MO, USA), and Esche- acepromazine maleate (16 mg/kg) and xylazine hydro-
chloride (3 mg/kg), followed 10 minutes later by an intra-richia coli (E. coli) was obtained from American Type
Culture Collection (catalog number 25922; Rockville, muscular injection of ketamine hydrochloride (50 mg/kg).
A carotid artery and jugular vein were cannulated forMD, USA). mAb 60.3 was kindly donated by Bristol-
Myers Squibb Pharmaceutical Research Institute (Seat- blood sampling and the infusion of solutions, respec-
tively. The peritoneal cavity was then penetrated, andtle, WA, USA).
a pediatric peritoneal catheter (Sil-Med Corporation,
Experimental design Tauton, MA, USA) was inserted and secured with a
purse-string suture.Two separate series of experiments were performed.
In series 1 experiments, circulating leukocytes were de- After pretreatment with either mustine or mAb 60.3,
the protocol for series 1 and 2 experiments was similar.pleted in New Zealand White (NZW) rabbits by a single
intravenous injection of mustine (1.2 mg/kg), dissolved A baseline arterial blood sample was first obtained, fol-
lowed by a washout exchange of the peritoneal cavityin sterile 0.9% saline solution, and administered three
days before the experiment [9]. In series 2 experiments, using 100 mL of sterile 0.9% saline solution that dwelled
for 15 minutes. A priming dose of creatinine (100 mg)mAb 60.3 (2 mg/kg) dissolved in sterile 0.9% saline solu-
tion was administered five minutes before the experi- dissolved in 20 mL of Normosol Rt (Abbott Laboratories,
North Chicago, IL, USA) was then infused intravenouslyment to inhibit PMN migration into the peritoneal cavity
[19]. This mAb is a mouse IgG2a directed against the over 10 minutes. A Normosol Rt solution containing
165 mg/dL creatinine was infused intravenously through-CD18 subunit of the CD11/CD18 molecule on leuko-
cytes [20] and has been previously shown to inhibit out the experiment at 1.2 mL/min to maintain the plasma
creatinine concentration at approximately 10 mg/dL.greater than 85% of PMN migration into the peritoneal
cavity of NZW rabbits under conditions similar to those After drainage of the washout exchange, 35 mL/kg of the
experimental dialysate were infused into the peritonealstudied here [19]. The effect of these interventions on
circulating PMNs and their migration into the peritoneal cavity. The experimental dialysate in each experiment
was either a sterile saline solution to which 4 3 106cavity and peritoneal permeability to protein in response
to bacterial peritonitis was evaluated by comparison with colony-forming units of E. coli were added or a sterile
saline solution without added bacteria. All dialysatescontrol experiments, in which a sterile 0.9% saline solu-
tion was injected intravenously instead of either mustine were warmed to 378C before infusion into the rabbit.
The study dwell was performed for six hours in series 1or mAb 60.3. Additional control experiments were also
performed without adding bacteria to the peritoneal cav- and eight hours in series 2 experiments. Two milliliters
of blood and 2.5 mL of dialysate were taken in series 1ity with or without pretreatment with mustine or mAb
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experiments at 0, 30, 60, 120, 240, and 360 minutes. These
same samples were taken at 0, 30, 60, 120, 240, 360, and
480 minutes in series 2 experiments. After taking the
final blood and dialysate samples, the peritoneal cavity
was drained by gravity as completely as possible, and
the drained volume was measured to the nearest millili-
ter using a graduated cylinder. Ten microliters of blood
and 100 mL of dialysate were taken from each sample
to determine total and differential leukocyte counts. All
samples were kept at 2208C until other assays were
performed. The rabbit was euthanized at the end of the
experiment by a barbiturate overdose.
Analytical
Total leukocytes in blood and dialysate were counted
using a hemacytometer. The percentage of PMNs in
Fig. 1. Leukocyte counts (white blood cells; WBCs) in peritoneal dialy-
blood and dialysate was determined using Wright’s stain. sate as a function of dwell time during series 1 experiments (pretreat-
ment with mustine). Results are shown after an intravenous injection ofPlasma and dialysate concentrations of creatinine and
mustine using dialysate containing E. coli (h; N 5 6), after an intravenousglucose were measured using an automated analyzer
injection of saline using dialysate containing E. coli (s; N 5 6), after an
(Beckman CX3, Fullerton, CA, USA), and total protein intravenous injection of mustine using a dialysate without bacteria (j;
N 5 6), and after an intravenous injection of saline using a dialysateconcentrations in plasma and dialysate were measured
without bacteria (d; N 5 6). Error bars denote 6 SEM, and doubleusing the Bio-Rad protein assay (Hercules, CA, USA).
asterisks denote significant differences (P , 0.01) in WBCs at the
specified sampling times.
Calculations
Peritoneal permeability to creatinine, glucose, and to-
tal protein was assessed by calculating the dialysate to
dose of mustine during study dwells containing bacteria.plasma (D/P) concentration ratios at each sampling time.
Circulating leukocyte counts before injection of mustine
Statistics were 6.8 6 0.7 3 106 per mL and were decreased (P ,
All results are expressed as mean 6 SEM. Differences 0.01) by 85 6 3% to 1.0 6 0.1 3 106 per mL three days
among the study groups were first tested for statistical later (immediately before the beginning of the study
significance by comparing the measured parameter as a dwell). The decrease in circulating PMNs was 93 6 3%.
function of time during the dwell using analysis of vari- Circulating leukocyte counts before the saline injection
ance (ANOVA) with repeated measures [23]. If signifi- (control rabbits) were 7.1 6 0.7 3 106 per mL and de-
cant differences among the study groups were identified creased (P , 0.01) slightly to 5.4 6 0.2 3 106 per mL
using this test, then the measured parameter at each three days later.
sampling time was compared among the study groups Figure 1 shows the dialysate leukocyte counts as a
using ANOVA and an unpaired Student’s t-test with function of dwell time during series 1 experiments. Dialy-
modified confidence limits computed by the Bonferroni sate leukocyte counts were low throughout the dwells
method. P values of less than 0.05 were considered sig- when bacteria was not added to the dialysate, irrespec-
nificant. Because of the limited number of replicates tive of whether saline or mustine was injected intrave-
performed in series 2 experiments without adding bacte-
nously three days earlier. When saline was injected intra-
ria to the dialysate (due to limited availability of mAb
venously three days before the study dwell and E. coli60.3), these data were not included in any statistical com-
was added to the dialysate, leukocyte counts were greaterparison.
(P , 0.01) than control levels (without bacteria added
to the peritoneal cavity) after 120, 240, and 360 minutes
RESULTS of the dwell, as expected. The percentage of dialysate
leukocytes that were PMNs at the end of these dwells wasSeries 1 experiments (pretreatment with mustine)
94 6 2%. An intravenous injection of mustine decreasedAn intravenous injection of mustine had a substantial
leukocyte migration into the peritoneal cavity in re-effect on the number of circulating leukocytes and
sponse to intraperitoneal administration of bacteria toPMNs. In these experiments, we used a dose of mustine
levels that were not different from those of the dwells(1.2 mg/kg) that was lower than that previously described
without bacteria added to the dialysate. The percentageof 1.75 mg/kg [9], because our preliminary experiments
showed a high mortality in rabbits treated with the higher of dialysate leukocytes that were PMNs at the end of all
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Fig. 2. Dialysate to plasma concentration ratios (D/P) for total protein
Fig. 3. Dialysate to plasma concentration ratios (D/P) for creatinineas a function of dwell time during series 1 experiments (pretreatment
as a function of dwell time during series 1 experiments (pretreatmentwith mustine). Symbols are: (h) after an intravenous injection of mus-
with mustine). Symbols are: (h) after an intravenous injection of mus-tine using dialysate containing E. coli (N 5 6); (s) after an intravenous
tine using dialysate containing E. coli (N 5 6); (s) after an intravenousinjection of saline using dialysate containing E. coli (N 5 6); (j) after
injection of saline using dialysate containing E. coli (N 5 6); (j) afteran intravenous injection of mustine using a dialysate without bacteria
an intravenous injection of mustine using a dialysate without bacteria(N 5 6); (d) after an intravenous injection of saline using a dialysate
(N 5 6); and (d) after an intravenous injection of saline using a dialysatewithout bacteria (N 5 6). Error bars denote 6 SEM, and double aster-
without bacteria (N 5 6). Error bars denote 6 SEM.isks denote significant differences (P , 0.01) in D/P values at the
specified sampling times.
was added to the infused dialysis solution, leukocyte
dwells when leukocyte counts remained low was 23 6 counts in the dialysate were substantially lower (P ,
7% (N 5 18). 0.01) after an intravenous injection of mAb 60.3 than
Figure 2 shows D/P concentration ratios for total pro- after an intravenous injection of saline. The percentage
tein as a function of dwell time during series 1 experi- of dialysate leukocytes that were PMNs was 36 6 9%
ments. Values of D/P for protein increased throughout and 95 6 1% after an intravenous injection of mAb
the dwells when bacteria was not added to the dialysate; 60.3 and saline, respectively. An intravenous injection
the rate of increase in protein D/P values was not differ-
of mAb 60.3 to rabbits not exposed to bacteria withinent from each other when either saline or mustine was
the peritoneal cavity per se did not result in changes ininjected intravenously three days earlier. These results
leukocyte migration into the peritoneal cavity.demonstrate that mustine had no direct effect on perito-
Figure 5 shows D/P concentration ratios of total pro-neal permeability to protein. When saline was injected
tein as a function of dwell time during series 2 experi-three days before the study dwell and E. coli was added
ments. An intravenous injection of mAb 60.3 substan-to the dialysate, D/P for protein was substantially higher
tially reduced the elevated D/P protein values when E.(P , 0.01) at 240 and 360 minutes. An intravenous injec-
coli was added to the infused dialysis solution. An intra-tion of mustine three days before the study dwell de-
venous injection of mAb 60.3 to rabbits not exposed tocreased protein D/P values in response to an intraperito-
bacteria within the peritoneal cavity did not change theneal administration of bacteria to levels that were not
values of D/P for protein.different from those of the dwells without bacteria added
Dialysate to plasma concentration ratios for creatinineto the dialysate.
and glucose during series 2 experiments were not signifi-Figure 3 shows D/P values for creatinine as a function
cantly different among the study groups and were compa-of dwell time during series 1 experiments. There were
rable to those observed during series 1 experiments (datano significant differences in D/P creatinine values among
not shown). Measured drained volumes in series 2 exper-the study groups. D/P values for glucose were also not
iments were similar among the study groups (Table 1).statistically different among the study groups (data not
shown). In these series 1 experiments, measured drained
volumes were similar among the different study groups
DISCUSSION(Table 1).
Administered in a single intravenous injection, mus-
Series 2 experiments (pretreatment with mAb 60.3) tine is short lived in the blood and depletes leukocytes
from the circulation by preventing replication of stemFigure 4 shows dialysate leukocyte counts as a function
of dwell time during series 2 experiments. When E. coli cells in the bone marrow [9]. Depletion of circulating
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Fig. 5. Dialysate to plasma concentration ratios (D/P) for total protein
as a function of dwell time during series 2 experiments (pretreatmentFig. 4. Leukocyte counts (WBCs) in peritoneal dialysate as a function
with mAb 60.3). Symbols are: (h) after an intravenous injection of mAbof dwell time during series 2 experiments (pretreatment with mAb
60.3 using dialysate containing E. coli (N 5 5); (s) after an intravenous60.3). Results are shown after an intravenous injection of mAb 60.3
injection of saline using dialysate containing E. coli (N 5 5); (j) afterusing dialysate containing E. coli (h; N 5 5), after an intravenous
an intravenous injection of mAb 60.3 using a dialysate without bacteriainjection of saline using dialysate containing E. coli (s; N 5 5), and
(N 5 2). Error bars denote 6 SEM, and single and double asterisksafter an intravenous injection of mAb 60.3 using a dialysate without
denote significant differences (P , 0.05 and P , 0.01, respectively) inbacteria (j; N 5 2). Error bars denote 6 SEM, and single and double
D/P for total protein at the specified sampling times.asterisks denote significant differences (P , 0.05 and P , 0.01, respec-
tively) in WBCs at the specified sampling times.
show that PMN activation and enhanced PMN migration
leukocytes in series 1 experiments blocked the enhanced into the peritoneal cavity does not alter peritoneal per-
migration of leukocytes into the peritoneal cavity that meability to small solutes or water. We have shown pre-
normally accompanies acute, bacterial peritonitis in the viously that peritoneal permeability to small solutes is
rabbit [19], demonstrating that leukocytes that migrate not necessarily increased during peritonitis in the rabbit
into the peritoneal cavity during peritonitis are derived under conditions similar to those studied here (abstract;
largely from the circulating pool. The inhibition of en- Liu et al, J Am Soc Nephrol 5:462, 1994); thus, the current
hanced leukocyte migration also abrogated the increase results are consistent with these earlier observations.
in peritoneal permeability to protein. Because PMNs are Disparate effects on peritoneal permeability to small
the predominant leukocyte migrating into the peritoneal solutes and protein could be explained by an increase
cavity during this early phase of the inflammatory re- in the effective pore size of the peritoneal capillary wall
sponse, these results suggest that PMNs play an impor- without an increase in the effective peritoneal surface
tant role in governing the increase in peritoneal perme- area [26, 27]. The mechanisms by which PMNs increase
ability to protein during peritonitis. peritoneal permeability to protein or the effective pore
The results from series 2 experiments provide further size of peritoneal capillaries, however, cannot be deter-
evidence that PMNs are important in altering peritoneal mined from the current experiments.
permeability to protein during peritonitis. Our results Several caveats regarding the interpretation of our
confirm previous work showing that an intravenous injec- experimental results are worthy of discussion. First, the
tion of mAb 60.3 sharply inhibits PMN migration into vascular space was assumed to be the source of the pro-
the peritoneal cavity [19], presumably by blocking the tein that appears in the peritoneal cavity, but this con-
binding of the b2-integrin CD11b/CD18 on PMNs to tention cannot be directly evaluated in these experi-
capillary endothelial cells, thereby inhibiting subsequent ments. Although the current results suggest that the
extravasation of PMNs [24, 25]. Furthermore, our results increased rate of protein loss to the peritoneal cavity is
show that inhibition of PMN activation and migration not due to protein released by E. coli (since D/P for
into the peritoneal cavity via an intravenous injection of protein is similar with and without added E. coli after
mAb 60.3 abrogates the increase in peritoneal perme- intravenous administration of mustine), it is possible that
ability to protein. Taken together, the results from series this increase is caused by protein secreted by PMNs;
1 and 2 experiments strongly support an important role however, this possibility appears unlikely. Second, our
for PMNs in governing increased protein loss during results show a greater inhibition of the enhanced loss of
peritonitis in the rabbit. protein by blocking PMN activation and migration into
the peritoneal cavity than in previous studies [17, 18].The results from both series 1 and 2 experiments also
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undergoing peritoneal dialysis, in Peritoneal Dialysis (3rd ed), ed-This discrepancy may be due to differences among spe-
ited by Nolph KD, Dordrecht, Kluwer Academic, 1989, pp 230–260
cies or to the degree of inhibition of PMN migration, as 6. Churchill DN, Taylor DW, Keshaviah PR: Adequacy of dialysis
and nutrition in continuous peritoneal dialysis: Association withwe showed more extensive inhibition than in the pre-
clinical outcomes. J Am Soc Nephrol 7:198–207, 1996viously reported studies. Third, it is important to note
7. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreo-
that the binding of mAb 60.3 to circulating PMNs not poulos DG, Page D, the Canada-USA (CANUSA) Peritoneal
Dialysis Study Group: Increased peritoneal membrane transportonly blocks PMN adhesion to capillary endothelial cells
is associated with decreased patient and technique survival forand prevents their extravasation, but also alters other
continuous peritoneal dialysis patients. J Am Soc Nephrol 9:1285–
cell functions such as cell activation [25, 28]. Since we 1292, 1998
8. Yeun JY, Kaysen GA: Acute phase proteins and peritoneal dialy-did not directly determine parameters of PMN activation
sate albumin loss are the main determinants of serum albumin inin the current experiments, we cannot exclusively attri-
peritoneal dialysis patients. Am J Kidney Dis 30:923–927, 1997
bute our results in series 2 experiments to either en- 9. Wedmore CV, Williams TJ: Control of vascular permeability by
polymorphonuclear leukocytes in inflammation. Nature 289:646–hanced PMN activation or migration into the peritoneal
650, 1981cavity. Finally, our results do not rule out a possible
10. Arfors K-E, Lundberg C, Lindbom L, Lundberg K, Beatty PG,
additive or consequential role for certain inflammatory Harlan JM: A monoclonal antibody to the membrane glycopro-
tein complex CD18 inhibits polymorphonuclear leukocyte accumu-mediators, such as prostanoids, nitric oxide, and cyto-
lation and plasma leakage in vivo. Blood 69:338–340, 1987kines, that have been previously shown to be elevated
11. Knight PR, Druskovich G, Tait AR, Johnson KJ: The role of
in peritoneal dialysate during peritonitis and in which neutrophils, oxidants, and proteases in the pathogenesis of acid
pulmonary injury. Anesthesiology 77:772–778, 1992dialysate concentrations correlate with enhanced rates
12. Shasby DM, Vanbenthuysen KM, Tate RM, Shasby SS, McMur-of their protein loss [29–32]. The relationships among
try I, Repine JE: Granulocytes mediate acute edematous lung
enhanced PMN migration, the release of inflammatory injury in rabbits and in isolated rabbit lungs perfused with phorbol
myristate acetate: Role of oxygen radicals. Am Rev Respir Dismediators, and increased protein loss during peritonitis
125:443–447, 1982remain to be explored further. Nevertheless, the current
13. Doerschuk CM, Quinlan WM, Doyle NA, Bullard DC, Vest-
experiments show that blocking PMN activation and mi- weber D, Jones ML, Takei F, Ward PA, Beaudet AL: The role
of P-selectin and ICAM-1 in acute lung injury as determined usinggration into the peritoneal cavity is sufficient to abrogate
blocking antibodies and mutant mice. J Immunol 157:4609–4614,the increase in protein loss during peritonitis.
1996
Based on the experiments described in this study, we 14. Kubes P, Suzuki M, Granger DN: Modulation of PAF-induced
leukocyte adherence and increased microvascular permeability.conclude that PMN migration into the peritoneal cavity
Am J Physiol 259:G859–G864, 1990is integrin dependent and that the increase in protein
15. Kubes P, Suzuki M, Granger DN: Platelet-activating factor-
loss during acute, gram-negative bacterial peritonitis in induced microvascular dysfunction: Role of adherent leukocytes.
the rabbit is PMN dependent. Am J Physiol 258:G158–G163, 1990
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